Molecular genetics and histopathologic features of adult distal nephron tumors

Urology

Volumn 60, Issue 6, 2002, Pages 941-946

  Polascik, Thomas J ^a   Bostwick, David G ^b   Cairns, Paul ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTWICK LABORATORIES   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CYTODIAGNOSIS; CANCER LOCALIZATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MEDULLARY CARCINOMA; MOLECULAR BIOLOGY; NEPHRON; ONCOCYTOMA; PRIORITY JOURNAL; REVIEW;

ADENOCARCINOMA, CLEAR CELL; ADENOMA, CHROMOPHOBE; ADENOMA, OXYPHILIC; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; HUMANS; KIDNEY NEOPLASMS; KIDNEY TUBULES, COLLECTING; KIDNEY TUBULES, DISTAL; NEOPLASMS, DUCTAL, LOBULAR, AND MEDULLARY;

EID: 0036898918     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01825-3     Document Type: Review

References (49)

1. Bostwick D.G., Eble J.N., Murphy G.P. Conference summary diagnosis and prognosis of renal cell carcinoma - 1997 workshop . Cancer. 80:1997;975-976.
2. MacLennan G.T., Farrow G.M., Bostwick D.G. Low-grade collecting duct carcinoma of the kidney report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin . Urology. 50:1997;679-684.
3. Bostwick D.G., Eble J.N. Diagnosis and classification of renal cell carcinoma. Urol Clin North Am. 26:1999;627-635.
4. Kovacs G. Molecular differential pathology of renal cell tumours. Histopathology. 22:1993;1-8.
5. Thoenes W., Storkel S., Rumpelt H.J., et al. Cytomorphological typing of renal cell carcinoma - a new approach. Eur Urol. 18:(suppl 2):1990;6-9.
6. Storkel S., Eble J.N., Adlakha K., et al. Classification of renal cell carcinoma Workgroup No. 1 . Cancer. 80:1997;987-989.
7. Zbar B., Brauch H., Talmadge C., et al. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature (Lond). 327:1987;721-724.
8. Gnarra J., Tory K., Weng Y., et al. VHL tumor suppressor gene mutations in renal carcinoma tumorigenesis. Nat Genet. 7:1994;85-90.
9. Clifford S.C., Prowse A.H., Affara N.A., et al. Inactivation of the von Hippel Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma evidence for a VHL-independent pathway in clear cell renal tumourigenesis . Genes Chrom Cancer. 22:1998;200-209.
10. Velickovic M., Delahunt B., Storkel S., et al. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance. Cancer Res. 61:2001;4815-4819.
11. Herman J.G., Latif F., Weng Y., et al. Silencing of the VHL tumor-suppressor gene by methylation in renal cell carcinoma. Proc Natl Acad Sci USA. 91:1994;9700-9704.
12. Stolle C., Glenn G., Zbar B., et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat. 12:1998;417-423.
13. Kovacs G. Molecular cytogenetics of renal cell tumors. Adv Cancer Res. 62:1993;89-124.
14. van den Berg E., van der Hout A.H., Oosterhuis J.W., et al. Cytogenetic analysis of epithelial renal-cell tumours relationship with a new histopathological classification . Int J Cancer. 55:1993;223-227.
15. Schmidt L., Duh F.M., Chen F., et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet. 16:1997;68-73.
16. Bonsib S.M. Risk and prognosis in renal neoplasms a pathologist's perspective . Urol Clin North Am. 26:1999;643-660.
17. Avery R.A., Harris J.E., Davis C.J. Jr, et al. Renal medullary carcinoma clinical and therapeutic aspects of a newly described tumor . Cancer. 78:1996;128-132.
18. Zippel L. Zur kenntnis der onkocyten. Virchows Arch Pathol Anat Physiol Klin Med 308: 360-382, 1942.
19. Klein M.J., Valensi Q.J. Proximal tubular adenomas of kidney with so-called oncocytic features a clinicopathologic study of 13 cases of a rarely reported neoplasm . Cancer. 38:1976;906-914.
20. Amin M.B., Crotty T.B., Tickoo S.K., et al. Renal oncocytoma a reappraisal of morphologic features with clinicopathologic findings in 80 cases . Am J Surg Pathol. 21:1997;1-12.
21. Storkel S., Pannen B., Thoenes W., et al. Intercalated cells as a probable source for the development of renal oncocytoma. Virchows Arch B Cell Pathol Mol Pathol. 56:1988;185-189.
22. Kovacs A., Storkel S., Thoenes W., et al. Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas. J Pathol. 167:1992;273-277.
23. Dobin S.M., Harris C.P., Reynolds J.A., et al. Cytogenetic abnormalities in renal oncocytic neoplasms. Genes Chromosom Cancer. 4:1992;25-31.
24. Brown J.A., Takahashi S., Alcaraz A., et al. Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1. J Urol. 156:1996;31-35.
25. van den Berg E., Dijkhuizen T., Storkel K.S., et al. Chromosomal changes in renal oncocytomas Evidence that t(5;11)(q35;q13) may characterize a second subgroup of oncocytomas . Cancer Genet Cytogenet. 79:1995;165-168.
26. Sinke R.J., Dijkhuizen T., Janssen B., et al. Fine mapping of the human renal oncocytoma-associated translocation (5;11)(q35;q13) breakpoint. Cancer Genet Cytogenet. 96:1997;95-101.
27. Neuhaus C., Dijkhuizen T., van den Berg E., et al. Involvement of the chromosomal region 11q13 in renal oncocytoma case report and literature review . Cancer Genet Cytogenet. 94:1997;95-98.
28. Kovacs G., Welter C., Wilkens L., et al. Renal oncocytoma - a phenotypic and genetic entity of renal parenchymal tumors. Am J Pathol. 134:1989;967-971.
29. Polascik T.J., Cairns P., Epstein J.I., et al. Distal nephron renal tumors microsatellite allelotype . Cancer Res. 56:1996;1892-1895.
30. Thrash-Bingham C.A., Salazar H., Greenberg R.E., et al. Loss of heterozygosity studies indicate that chromosome arm 1p harbors a tumor suppressor gene for renal oncoytomas. Genes Chromosom Cancer. 16:1996;64-67.
31. Weirich G., Glenn G., Junker K., et al. Familial renal oncocytoma clinicopathological study of 5 families . J Urol. 160:1998;335-340.
32. Thoenes W., Storkel S.T., Rumpelt H.J. Human chromophobe cell renal carcinoma. Virchows Arch. 48:1985;207-217.
33. Storkel S., Steart P.V., Drenckhahn D., et al. The human chromophobe cell renal carcinoma its probable relation to intercalated cells of the collecting duct . Virchows Arch B Cell Pathol. 56:1989;237-245.
34. Latham B., Dickersin G.R., Oliva E. Subtypes of chromophobe cell renal carcinoma an ultrastructural and histochemical study of 13 cases . Am J Surg Pathol. 23:1999;530-535.
35. Thoenes W., Storkel S., Rumpelt H.J., et al. Chromophobe renal cell carcinoma and its variants a report of 32 cases . J Pathol. 155:1988;277-287.
36. MacLennan G.T., Farrow G.M., Bostwick D.G. Immunohistochemistry in the evaluation of renal cell carcinoma a critical appraisal . J Urol Pathol. 6:1997;195-203.
37. Taki A., Nakatani Y., Misugi K., et al. Chromophobe renal cell carcinoma an immunohistochemical study of 21 Japanese cases . Mod Pathol. 12:1999;310-317.
38. Speicher M.R., Schoell B., du Manoir S., et al. Specific loss of chromosomes 1, 2, 6, 10, 13, 17 and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol. 145:1994;356-364.
39. Kenck C., Wilhelm M., Bugert P., et al. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas. J Pathol. 179:1996;157-161.
40. Rumpelt H.J., Storkel S., Moll R., et al. Bellini duct carcinoma further evidence for this rare variant of renal cell carcinoma . Histopathology. 18:1991;115-122.
41. Storkel S., van den Berg E. Morphological classification of renal cancer. World J Urol. 13:1995;153-158.
42. Fuzesi L., Cober M., Mittermayer C. Collecting duct carcinoma cytogenetic characterization . Histopathology. 21:1992;155-160.
43. Fleming S., Symes C.E. The distribution of cytokeratin antigens in the kidney and in renal tumours. Histopathology. 11:1987;157-170.
44. Gregori-Romero M.A., Morell-Quadreny L., Llombart-Bosch A. Cytogenetic analysis of three primary Bellini duct carcinomas. Genes Chromosom Cancer. 15:1996;170-172.
45. Steiner G., Cairns P., Polascik T.J., et al. High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma region of minimal deletion at 1q32.1-32.2 . Cancer Res. 56:1996;5044-5046.
46. Selli C., Amorosi A., Vona G., et al. Retrospective evaluation of c-erbB-2 oncogene amplification using competitive PCR in collecting duct carcinoma of the kidney. J Urol. 158:1997;245-247.
47. Davis C.J. Jr, Mostofi F.K., Sesterhenn I.A. Renal medullary carcinoma the seventh sickle cell nephropathy . Am J Surg Pathol. 19:1995;1-11.
48. Stahlschmidt J., Cullinane C., Roberts P., et al. Renal medullary carcinoma prolonged remission with chemotherapy, immunohistochemical characterization and evidence of bcr/abl rearrangement . Med Pediatr Oncol. 33:1999;551-557.
49. Wesche W.A., Wilimas J., Khare V., et al. Renal medullary carcinoma a potential sickle cell nephropathy of children and adolescents . Pediatr Pathol Lab Med. 18:1998;97-113.